{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T01:54:18Z","timestamp":1791338058291,"version":"4.3.1"},"reference-count":133,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000890","name":"NMSS","doi-asserted-by":"publisher","award":["RG 4853A3\/2"],"award-info":[{"award-number":["RG 4853A3\/2"]}],"id":[{"id":"10.13039\/100000890","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["R01 NS081141-0\u200b1A1"],"award-info":[{"award-number":["R01 NS081141-0\u200b1A1"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["R21NS075198"],"award-info":[{"award-number":["R21NS075198"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Steroid Biochemistry and Molecular Biology"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1016\/j.jsbmb.2016.01.006","type":"journal-article","created":{"date-parts":[[2016,1,15]],"date-time":"2016-01-15T04:14:31Z","timestamp":1452831271000},"page":"43-52","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":41,"special_numbering":"C","title":["Nudging oligodendrocyte intrinsic signaling to remyelinate and repair: Estrogen receptor ligand effects"],"prefix":"10.1016","volume":"160","author":[{"given":"Anna J.","family":"Khalaj","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2630-9850","authenticated-orcid":false,"given":"Jonathan","family":"Hasselmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Augello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9811-9007","authenticated-orcid":false,"given":"Spencer","family":"Moore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7608-4763","authenticated-orcid":false,"given":"Seema K.","family":"Tiwari-Woodruff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.jsbmb.2016.01.006_bib0005","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S1474-4422(14)70256-X","article-title":"Pathological mechanisms in progressive multiple sclerosis","volume":"14","author":"Mahad","year":"2015","journal-title":"Lancet Neurol."},{"issue":"11","key":"10.1016\/j.jsbmb.2016.01.006_bib0010","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1212\/WNL.0000000000000768","article-title":"Atlas of Multiple Sclerosis 2013: A growing global problem with widespread inequity","volume":"83","author":"Browne","year":"2014","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.jsbmb.2016.01.006_bib0015","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1046\/j.1365-2990.2000.00217.x","article-title":"Staging of multiple sclerosis (MS) lesions: pathology of the time frame of MS","volume":"26","author":"van der Valk","year":"2000","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"10.1016\/j.jsbmb.2016.01.006_bib0020","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/j.1600-065X.1991.tb00596.x","article-title":"Non-deletional mechanisms of peripheral and central tolerance: studies with transgenic mice with tissue-specific expression of a foreign MHC class I antigen","volume":"122","author":"Hammerling","year":"1991","journal-title":"Immunol. Rev."},{"issue":"2","key":"10.1016\/j.jsbmb.2016.01.006_bib0025","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1002\/ana.21744","article-title":"Pathogenic CD8(+) T cells in multiple sclerosis","volume":"66","author":"Friese","year":"2009","journal-title":"Ann. Neurol."},{"issue":"12","key":"10.1016\/j.jsbmb.2016.01.006_bib0030","first-page":"921","article-title":"Multiple sclerosis from Charcot and Vulpian to the present time","volume":"138","author":"Rascol","year":"1982","journal-title":"Rev. Neurol. (Paris)"},{"key":"10.1016\/j.jsbmb.2016.01.006_bib0035","article-title":"The search for the target antigens of multiple sclerosis, part 1: autoreactive CD4+ T lymphocytes as pathogenic effectors and therapeutic targets","author":"Hohlfeld","year":"2015","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.jsbmb.2016.01.006_bib0040","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.jaut.2015.06.010","article-title":"The immunogenetics of multiple sclerosis: a comprehensive review","volume":"64","author":"Hollenbach","year":"2016","journal-title":"J. Autoimmun."},{"issue":"5","key":"10.1016\/j.jsbmb.2016.01.006_bib0045","doi-asserted-by":"crossref","first-page":"506","DOI":"10.2174\/187152712801661248","article-title":"Pathology of multiple sclerosis","volume":"11","author":"Kipp","year":"2012","journal-title":"CNS Neurol. Disord. Drug Targets"},{"issue":"Pt 10","key":"10.1016\/j.jsbmb.2016.01.006_bib0050","doi-asserted-by":"crossref","first-page":"2925","DOI":"10.1093\/brain\/aws189","article-title":"Meningeal inflammation plays a role in the pathology of primary progressive multiple sclerosis","volume":"135","author":"Choi","year":"2012","journal-title":"Brain"},{"issue":"Pt 5","key":"10.1016\/j.jsbmb.2016.01.006_bib0055","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1093\/brain\/awp070","article-title":"The relation between inflammation and neurodegeneration in multiple sclerosis brains","volume":"132","author":"Frischer","year":"2009","journal-title":"Brain"},{"issue":"1","key":"10.1016\/j.jsbmb.2016.01.006_bib0060","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.pathophys.2010.04.004","article-title":"The relevance of animal models in multiple sclerosis research","volume":"18","author":"Denic","year":"2011","journal-title":"Pathophysiology"},{"issue":"2","key":"10.1016\/j.jsbmb.2016.01.006_bib0065","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1002\/mus.880030207","article-title":"Determinants of conduction velocity in myelinated nerve fibers","volume":"3","author":"Waxman","year":"1980","journal-title":"Muscle Nerve"},{"issue":"5","key":"10.1016\/j.jsbmb.2016.01.006_bib0070","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/S0896-6273(00)80470-5","article-title":"Dorsal spinal cord neuroepithelium generates astrocytes but not oligodendrocytes","volume":"20","author":"Pringle","year":"1998","journal-title":"Neuron"},{"issue":"2","key":"10.1016\/j.jsbmb.2016.01.006_bib0075","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1242\/dev.118.2.563","article-title":"Oligodendrocyte precursors originate at the ventral ventricular zone dorsal to the ventral midline region in the embryonic rat spinal cord","volume":"118","author":"Noll","year":"1993","journal-title":"Development"},{"issue":"5","key":"10.1016\/j.jsbmb.2016.01.006_bib0080","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S0166-2236(02)02145-8","article-title":"Origin and molecular specification of oligodendrocytes in the telencephalon","volume":"25","author":"Qi","year":"2002","journal-title":"Trends Neurosci."},{"issue":"2","key":"10.1016\/j.jsbmb.2016.01.006_bib0085","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/nn1620","article-title":"Competing waves of oligodendrocytes in the forebrain and postnatal elimination of an embryonic lineage","volume":"9","author":"Kessaris","year":"2006","journal-title":"Nat. Neurosci."},{"issue":"6","key":"10.1016\/j.jsbmb.2016.01.006_bib0090","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/0962-8924(93)90213-K","article-title":"The oligodendrocyte and its many cellular processes","volume":"3","author":"Pfeiffer","year":"1993","journal-title":"Trends Cell Biol."},{"issue":"6053","key":"10.1016\/j.jsbmb.2016.01.006_bib0095","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1038\/319499a0","article-title":"Proliferating bipotential glial progenitor cells in adult rat optic nerve","volume":"319","author":"Ffrench-Constant","year":"1986","journal-title":"Nature"},{"issue":"23","key":"10.1016\/j.jsbmb.2016.01.006_bib0100","doi-asserted-by":"crossref","first-page":"9752","DOI":"10.1523\/JNEUROSCI.0805-13.2013","article-title":"Ascl1\/Mash1 promotes brain oligodendrogenesis during myelination and remyelination","volume":"33","author":"Nakatani","year":"2016","journal-title":"J. Neurosci."},{"issue":"3","key":"10.1016\/j.jsbmb.2016.01.006_bib0105","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.mcn.2004.06.015","article-title":"Increased expression of Nkx2.2 and Olig2 identifies reactive oligodendrocyte progenitor cells responding to demyelination in the adult CNS","volume":"27","author":"Fancy","year":"2004","journal-title":"Mol. Cell. Neurosci."},{"issue":"6","key":"10.1016\/j.jsbmb.2016.01.006_bib0110","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/S0301-0082(02)00058-8","article-title":"Regulation of oligodendrocyte development in the vertebrate CNS","volume":"67","author":"Miller","year":"2002","journal-title":"Prog. Neurobiol."},{"issue":"1","key":"10.1016\/j.jsbmb.2016.01.006_bib0115","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1159\/000112275","article-title":"Triiodothyronine stimulation of oligodendroglial differentiation and myelination. A developmental study","volume":"7","author":"Almazan","year":"1985","journal-title":"Dev. Neurosci."},{"issue":"3","key":"10.1016\/j.jsbmb.2016.01.006_bib0120","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1002\/(SICI)1097-4547(19960201)43:3<289::AID-JNR4>3.0.CO;2-F","article-title":"Ciliary neurotrophic factor selectively protects human oligodendrocytes from tumor necrosis factor-mediated injury","volume":"43","author":"D'Souza","year":"1996","journal-title":"J. Neurosci. Res."},{"issue":"2\u20134","key":"10.1016\/j.jsbmb.2016.01.006_bib0125","first-page":"99","article-title":"Insulin-like growth factor I promotes cell proliferation and oligodendroglial commitment in rat glial progenitor cells developing in vitro","volume":"21","author":"McMorris","year":"1988","journal-title":"J. Neurosci. Res."},{"issue":"1","key":"10.1016\/j.jsbmb.2016.01.006_bib0130","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.neuroimage.2011.11.094","article-title":"Diffusion tensor imaging of white matter tract evolution over the lifespan","volume":"60","author":"Lebel","year":"2011","journal-title":"Neuroimage"},{"issue":"10","key":"10.1016\/j.jsbmb.2016.01.006_bib0135","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.tcb.2011.06.004","article-title":"Central nervous system myelin: structure, synthesis and assembly","volume":"21","author":"Aggarwal","year":"2011","journal-title":"Trends Cell Biol."},{"issue":"11","key":"10.1016\/j.jsbmb.2016.01.006_bib0140","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/nrn2480","article-title":"Remyelination in the CNS: from biology to therapy","volume":"9","author":"Franklin","year":"2008","journal-title":"Nat. Rev. Neurosci."},{"issue":"2","key":"10.1016\/j.jsbmb.2016.01.006_bib0145","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1002\/ana.410330203","article-title":"Multiple sclerosis: remyelination of nascent lesions","volume":"33","author":"Prineas","year":"1993","journal-title":"Ann. Neurol."},{"issue":"5","key":"10.1016\/j.jsbmb.2016.01.006_bib0150","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1002\/ana.20812","article-title":"Complementary patterns of gene expression by human oligodendrocyte progenitors and their environment predict determinants of progenitor maintenance and differentiation","volume":"59","author":"Sim","year":"2006","journal-title":"Ann. Neurol."},{"issue":"6807","key":"10.1016\/j.jsbmb.2016.01.006_bib0155","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1038\/35039559","article-title":"Regenerating the damaged central nervous system","volume":"407","author":"Horner","year":"2000","journal-title":"Nature"},{"issue":"30","key":"10.1016\/j.jsbmb.2016.01.006_bib0160","doi-asserted-by":"crossref","first-page":"7907","DOI":"10.1523\/JNEUROSCI.1299-06.2006","article-title":"Origin of oligodendrocytes in the subventricular zone of the adult brain","volume":"26","author":"Menn","year":"2006","journal-title":"J. Neurosci."},{"issue":"2","key":"10.1016\/j.jsbmb.2016.01.006_bib0165","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1002\/glia.20357","article-title":"Axonal degeneration stimulates the formation of NG2+ cells and oligodendrocytes in the mouse","volume":"54","author":"Nielsen","year":"2006","journal-title":"Glia"},{"issue":"1\u20132","key":"10.1016\/j.jsbmb.2016.01.006_bib0170","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.jns.2007.08.004","article-title":"Endogenous or exogenous oligodendrocytes for remyelination","volume":"265","author":"Blakemore","year":"2008","journal-title":"J. Neurol. Sci."},{"issue":"Pt. 7","key":"10.1016\/j.jsbmb.2016.01.006_bib0175","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1093\/brain\/awn096","article-title":"Differentiation block of oligodendroglial progenitor cells as a cause for remyelination failure in chronic multiple sclerosis","volume":"131","author":"Kuhlmann","year":"2008","journal-title":"Brain"},{"issue":"Pt. 12","key":"10.1016\/j.jsbmb.2016.01.006_bib0180","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.1093\/brain\/122.12.2279","article-title":"A quantitative analysis of oligodendrocytes in multiple sclerosis lesions. A study of 113 cases","volume":"122","author":"Lucchinetti","year":"1999","journal-title":"Brain"},{"issue":"9","key":"10.1016\/j.jsbmb.2016.01.006_bib0185","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1038\/nrn917","article-title":"Why does remyelination fail in multiple sclerosis?","volume":"3","author":"Franklin","year":"2002","journal-title":"Nat. Rev. Neurosci."},{"issue":"2","key":"10.1016\/j.jsbmb.2016.01.006_bib0190","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1002\/1531-8249(199908)46:2<144::AID-ANA3>3.0.CO;2-K","article-title":"Demyelination in primate autoimmune encephalomyelitis and acute multiple sclerosis lesions: a case for antigen-specific antibody mediation","volume":"46","author":"Raine","year":"1999","journal-title":"Ann. Neurol."},{"issue":"Suppl. 1","key":"10.1016\/j.jsbmb.2016.01.006_bib0195","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s00415-008-1004-6","article-title":"The biology of CNS remyelination: the key to therapeutic advances","volume":"255","author":"Franklin","year":"2008","journal-title":"J. Neurol"},{"issue":"Pt. 12","key":"10.1016\/j.jsbmb.2016.01.006_bib0200","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1093\/brain\/121.12.2221","article-title":"Oligodendrocyte progenitors are present in the normal adult human CNS and in the lesions of multiple sclerosis","volume":"121","author":"Scolding","year":"1998","journal-title":"Brain"},{"issue":"1","key":"10.1016\/j.jsbmb.2016.01.006_bib0205","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.yfrne.2012.01.001","article-title":"Multiple sclerosis: neuroprotective alliance of estrogen-progesterone and gender","volume":"33","author":"Kipp","year":"2012","journal-title":"Front. Neuroendocrinol."},{"issue":"2","key":"10.1016\/j.jsbmb.2016.01.006_bib0210","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.ydbio.2006.10.007","article-title":"Induction of oligodendrocyte differentiation by Olig2 and Sox10: evidence for reciprocal interactions and dosage-dependent mechanisms","volume":"302","author":"Liu","year":"2007","journal-title":"Dev. Biol."},{"key":"10.1016\/j.jsbmb.2016.01.006_bib0215","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1146\/annurev-neuro-061010-113629","article-title":"Myelin regeneration: a recapitulation of development?","volume":"34","author":"Fancy","year":"2016","journal-title":"Annu. Rev. Neurosci."},{"issue":"5","key":"10.1016\/j.jsbmb.2016.01.006_bib0220","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1111\/j.1471-4159.2009.06071.x","article-title":"IGF-1-stimulated protein synthesis in oligodendrocyte progenitors requires PI3K\/mTOR\/Akt and MEK\/ERK pathways","volume":"109","author":"Bibollet-Bahena","year":"2009","journal-title":"J. Neurochem."},{"issue":"21","key":"10.1016\/j.jsbmb.2016.01.006_bib0225","doi-asserted-by":"crossref","first-page":"6860","DOI":"10.1523\/JNEUROSCI.0232-09.2009","article-title":"Akt signals through the mammalian target of rapamycin pathway to regulate CNS myelination","volume":"29","author":"Narayanan","year":"2009","journal-title":"J. Neurosci."},{"issue":"19","key":"10.1016\/j.jsbmb.2016.01.006_bib0230","doi-asserted-by":"crossref","first-page":"6367","DOI":"10.1523\/JNEUROSCI.0234-09.2009","article-title":"Activation of the mammalian target of rapamycin (mTOR) is essential for oligodendrocyte differentiation","volume":"29","author":"Tyler","year":"2009","journal-title":"J. Neurosci."},{"issue":"3","key":"10.1016\/j.jsbmb.2016.01.006_bib0235","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1002\/glia.22281","article-title":"Erk1\/2 MAPK and mTOR signaling sequentially regulates progression through distinct stages of oligodendrocyte differentiation","volume":"60","author":"Guardiola-Diaz","year":"2012","journal-title":"Glia"},{"issue":"5","key":"10.1016\/j.jsbmb.2016.01.006_bib0240","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1523\/JNEUROSCI.4814-11.2012","article-title":"Arrest of myelination and reduced axon growth when Schwann cells lack mTOR","volume":"32","author":"Sherman","year":"2012","journal-title":"J. Neurosci."},{"issue":"2","key":"10.1016\/j.jsbmb.2016.01.006_bib0245","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1385\/MB:31:2:151","article-title":"The ERK cascade: a prototype of MAPK signaling","volume":"31","author":"Rubinfeld","year":"2005","journal-title":"Mol. Biotechnol."},{"issue":"48","key":"10.1016\/j.jsbmb.2016.01.006_bib0250","doi-asserted-by":"crossref","first-page":"16031","DOI":"10.1523\/JNEUROSCI.3360-14.2014","article-title":"Role of ERK1\/2 MAPK signaling in the maintenance of myelin and axonal integrity in the adult CNS","volume":"34","author":"Ishii","year":"2014","journal-title":"J. Neurosci."},{"issue":"8","key":"10.1016\/j.jsbmb.2016.01.006_bib0255","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1002\/glia.22863","article-title":"Oligodendrocyte generation during mouse development","volume":"63","author":"Takebayashi","year":"2015","journal-title":"Glia"},{"key":"10.1016\/j.jsbmb.2016.01.006_bib0260","article-title":"Oligodendrocyte progenitor programming and reprogramming: toward myelin regeneration","author":"Lopez Juarez","year":"2015","journal-title":"Brain Res."},{"issue":"6","key":"10.1016\/j.jsbmb.2016.01.006_bib0265","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1002\/ana.1015","article-title":"Platelet-derived growth factor-alpha receptor-positive oligodendroglia are frequent in multiple sclerosis lesions","volume":"49","author":"Maeda","year":"2001","journal-title":"Ann. Neurol."},{"issue":"2","key":"10.1016\/j.jsbmb.2016.01.006_bib0270","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1006\/mcne.1999.0771","article-title":"Distinctive patterns of PDGF-A, FGF-2, IGF-I, and TGF-beta1 gene expression during remyelination of experimentally-induced spinal cord demyelination","volume":"14","author":"Hinks","year":"1999","journal-title":"Mol. Cell. Neurosci."},{"issue":"9","key":"10.1016\/j.jsbmb.2016.01.006_bib0275","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1242\/dev.127.9.1961","article-title":"The regulation of proliferation and differentiation in oligodendrocyte progenitor cells by alphaV integrins","volume":"127","author":"Blaschuk","year":"2000","journal-title":"Development"},{"issue":"8","key":"10.1016\/j.jsbmb.2016.01.006_bib0280","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1038\/cdd.2014.35","article-title":"Tumor necrosis factor-alpha impairs oligodendroglial differentiation through a mitochondria-dependent process","volume":"21","author":"Bonora","year":"2014","journal-title":"Cell Death Differ."},{"issue":"18","key":"10.1016\/j.jsbmb.2016.01.006_bib0285","doi-asserted-by":"crossref","first-page":"7046","DOI":"10.1523\/JNEUROSCI.21-18-07046.2001","article-title":"Interleukin-1beta promotes repair of the CNS","volume":"21","author":"Mason","year":"2001","journal-title":"J. Neurosci."},{"issue":"24","key":"10.1016\/j.jsbmb.2016.01.006_bib0290","doi-asserted-by":"crossref","first-page":"11062","DOI":"10.1073\/pnas.1006301107","article-title":"CXCR4 promotes differentiation of oligodendrocyte progenitors and remyelination","volume":"107","author":"Patel","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"4","key":"10.1016\/j.jsbmb.2016.01.006_bib0295","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1002\/jnr.490190412","article-title":"Effects of insulin and insulin-like growth factor (IGF-I) on oligodendrocyte-enriched glial cultures","volume":"19","author":"van der Pal","year":"1988","journal-title":"J. Neurosci. Res."},{"issue":"11\u201312","key":"10.1016\/j.jsbmb.2016.01.006_bib0300","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.1016\/j.molimm.2009.04.014","article-title":"ERB-041, a selective ER beta agonist, inhibits iNOS production in LPS-activated peritoneal macrophages of endometriosis via suppression of NF-kappaB activation","volume":"46","author":"Xiu-li","year":"2009","journal-title":"Mol. Immunol."},{"issue":"3","key":"10.1016\/j.jsbmb.2016.01.006_bib0305","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1002\/jnr.490400302","article-title":"Basic fibroblast growth factor down-regulates myelin basic protein gene expression and alters myelin compaction of mature oligodendrocytes in vitro","volume":"40","author":"Fressinaud","year":"1995","journal-title":"J. Neurosci. Res."},{"issue":"1","key":"10.1016\/j.jsbmb.2016.01.006_bib0310","first-page":"80","article-title":"Why are growth factors important in oligodendrocyte physiology?","volume":"48","author":"Dubois-Dalcq","year":"2000","journal-title":"Pathol. Biol. (Paris)"},{"issue":"4","key":"10.1016\/j.jsbmb.2016.01.006_bib0315","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/0896-6273(93)90173-O","article-title":"Insulin-like growth factor I increases brain growth and central nervous system myelination in transgenic mice","volume":"10","author":"Carson","year":"1993","journal-title":"Neuron"},{"issue":"4","key":"10.1016\/j.jsbmb.2016.01.006_bib0320","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1002\/glia.20469","article-title":"Insulin-like growth factor type 1 receptor signaling in the cells of oligodendrocyte lineage is required for normal in vivo oligodendrocyte development and myelination","volume":"55","author":"Zeger","year":"2007","journal-title":"Glia"},{"issue":"Pt. 9","key":"10.1016\/j.jsbmb.2016.01.006_bib0325","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1093\/brain\/awf216","article-title":"Re-expression of PSA-NCAM by demyelinated axons: an inhibitor of remyelination in multiple sclerosis?","volume":"125","author":"Charles","year":"2002","journal-title":"Brain"},{"issue":"2","key":"10.1016\/j.jsbmb.2016.01.006_bib0330","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0092-8674(03)00810-9","article-title":"F3\/contactin acts as a functional ligand for Notch during oligodendrocyte maturation","volume":"115","author":"Hu","year":"2003","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.jsbmb.2016.01.006_bib0335","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.ydbio.2005.03.020","article-title":"Wnt signaling controls the timing of oligodendrocyte development in the spinal cord","volume":"282","author":"Shimizu","year":"2005","journal-title":"Dev. Biol."},{"issue":"47","key":"10.1016\/j.jsbmb.2016.01.006_bib0340","doi-asserted-by":"crossref","first-page":"36378","DOI":"10.1074\/jbc.M607314200","article-title":"The structure of the Lingo-1 ectodomain: a module implicated in central nervous system repair inhibition","volume":"281","author":"Mosyak","year":"2006","journal-title":"J. Biol. Chem."},{"issue":"10","key":"10.1016\/j.jsbmb.2016.01.006_bib0345","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1002\/glia.22367","article-title":"Myelin debris regulates inflammatory responses in an experimental demyelination animal model and multiple sclerosis lesions","volume":"60","author":"Clarner","year":"2012","journal-title":"Glia"},{"issue":"2","key":"10.1016\/j.jsbmb.2016.01.006_bib0350","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1002\/ana.23788","article-title":"Digestion products of the PH20 hyaluronidase inhibit remyelination","volume":"73","author":"Preston","year":"2013","journal-title":"Ann. Neurol."},{"issue":"11","key":"10.1016\/j.jsbmb.2016.01.006_bib0355","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1038\/nrd2358","article-title":"Novel therapeutic strategies for multiple sclerosis?a multifaceted adversary","volume":"7","author":"Lopez-Diego","year":"2008","journal-title":"Nat. Rev. Drug Discov."},{"issue":"6","key":"10.1016\/j.jsbmb.2016.01.006_bib0360","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1038\/nri2550","article-title":"Autoimmune T cell responses in the central nervous system","volume":"9","author":"Goverman","year":"2009","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jsbmb.2016.01.006_bib0365","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.expneurol.2015.02.006","article-title":"Inhibition of LINGO-1 promotes functional recovery after experimental spinal cord demyelination","volume":"266","author":"Zhang","year":"2015","journal-title":"Exp. Neurol."},{"issue":"4","key":"10.1016\/j.jsbmb.2016.01.006_bib0370","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.mcn.2010.07.009","article-title":"LINGO-1-mediated inhibition of oligodendrocyte differentiation does not require the leucine-rich repeats and is reversed by p75(NTR) antagonists","volume":"45","author":"Bourikas","year":"2010","journal-title":"Mol. Cell. Neurosci."},{"issue":"14","key":"10.1016\/j.jsbmb.2016.01.006_bib0375","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.4103\/1673-5374.137586","article-title":"Strategies for myelin regeneration: lessons learned from development","volume":"9","author":"Bhatt","year":"2014","journal-title":"Neural Regen. Res."},{"issue":"7555","key":"10.1016\/j.jsbmb.2016.01.006_bib0380","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1038\/nature14335","article-title":"Drug-based modulation of endogenous stem cells promotes functional remyelination in vivo","volume":"522","author":"Najm","year":"2015","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.jsbmb.2016.01.006_bib0385","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/nrn3856","article-title":"The neuroprotective actions of oestradiol and oestrogen receptors","volume":"16","author":"Arevalo","year":"2015","journal-title":"Nat. Rev. Neurosci."},{"issue":"2","key":"10.1016\/j.jsbmb.2016.01.006_bib0390","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.phrs.2005.03.002","article-title":"From clinical evidence to molecular mechanisms underlying neuroprotection afforded by estrogens","volume":"52","author":"Amantea","year":"2005","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.jsbmb.2016.01.006_bib0395","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.jsbmb.2012.11.006","article-title":"Neuroprotection by gonadal steroid hormones in acute brain damage requires cooperation with astroglia and microglia","volume":"137","author":"Johann","year":"2013","journal-title":"J. Steroid Biochem. Mol. Biol."},{"issue":"138","key":"10.1016\/j.jsbmb.2016.01.006_bib0400","doi-asserted-by":"crossref","first-page":"pe29","DOI":"10.1126\/stke.2002.138.pe29","article-title":"Estrogen actions in the brain","volume":"2002","author":"Wang","year":"2002","journal-title":"Sci. STKE"},{"issue":"3","key":"10.1016\/j.jsbmb.2016.01.006_bib0405","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S1074-5521(01)00006-0","article-title":"The estrogen receptor: a structure-based approach to the design of new specific hormone-receptor combinations","volume":"8","author":"Tedesco","year":"2001","journal-title":"Chem. Biol."},{"issue":"1","key":"10.1016\/j.jsbmb.2016.01.006_bib0410","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1007\/s12016-010-8203-5","article-title":"Estrogen receptors in immunity and autoimmunity","volume":"40","author":"Cunningham","year":"2016","journal-title":"Clin. Rev. Allergy Immunol."},{"issue":"1","key":"10.1016\/j.jsbmb.2016.01.006_bib0415","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0928-8244(03)00202-5","article-title":"Regulation of innate and adaptive immunity by the female sex hormones oestradiol and progesterone","volume":"38","author":"Beagley","year":"2003","journal-title":"FEMS Immunol. Med. Microbiol."},{"key":"10.1016\/j.jsbmb.2016.01.006_bib0420","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1210\/rp.57.1.357","article-title":"Estrogen actions throughout the brain","volume":"57","author":"McEwen","year":"2002","journal-title":"Recent Prog. Horm. Res."},{"issue":"Suppl","key":"10.1016\/j.jsbmb.2016.01.006_bib0425","doi-asserted-by":"crossref","first-page":"S38","DOI":"10.1002\/ana.410360712","article-title":"Pregnancy and multiple sclerosis","volume":"36","author":"Abramsky","year":"1994","journal-title":"Ann. Neurol."},{"issue":"5","key":"10.1016\/j.jsbmb.2016.01.006_bib0430","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1056\/NEJM199807303390501","article-title":"Rate of pregnancy-related relapse in multiple sclerosis: pregnancy in multiple sclerosis group","volume":"339","author":"Confavreux","year":"1998","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.jsbmb.2016.01.006_bib0435","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/BF02207955","article-title":"The role of pregnancy in the course and aetiology of rheumatoid arthritis","volume":"11","author":"Da Silva","year":"1992","journal-title":"Clin. Rheumatol."},{"issue":"1","key":"10.1016\/j.jsbmb.2016.01.006_bib0440","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1159\/000367640","article-title":"Pregnancy in multiple sclerosis","volume":"72","author":"Hellwig","year":"2014","journal-title":"Eur. Neurol."},{"issue":"5","key":"10.1016\/j.jsbmb.2016.01.006_bib0445","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1177\/1352458513519840","article-title":"Pregnancy: sex and hormonal factors in multiple sclerosis","volume":"20","author":"Miller","year":"2014","journal-title":"Mult. Scler."},{"issue":"6","key":"10.1016\/j.jsbmb.2016.01.006_bib0450","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1212\/WNL.52.6.1230","article-title":"Estriol ameliorates autoimmune demyelinating disease: implications for multiple sclerosis","volume":"52","author":"Kim","year":"1999","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.jsbmb.2016.01.006_bib0455","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.4049\/jimmunol.166.3.2080","article-title":"Low-dose estrogen therapy ameliorates experimental autoimmune encephalomyelitis in two different inbred mouse strains","volume":"166","author":"Bebo","year":"2001","journal-title":"J. Immunol."},{"issue":"2","key":"10.1016\/j.jsbmb.2016.01.006_bib0460","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/0165-5728(94)90030-2","article-title":"Estrogen induces a potent suppression of experimental autoimmune encephalomyelitis and collagen-induced arthritis in mice","volume":"53","author":"Jansson","year":"1994","journal-title":"J. Neuroimmunol."},{"issue":"4","key":"10.1016\/j.jsbmb.2016.01.006_bib0465","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1002\/ana.10301","article-title":"Treatment of multiple sclerosis with the pregnancy hormone estriol","volume":"52","author":"Sicotte","year":"2002","journal-title":"Ann. Neurol."},{"issue":"1","key":"10.1016\/j.jsbmb.2016.01.006_bib0470","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S1474-4422(15)00322-1","article-title":"Estriol combined with glatiramer acetate for women with relapsing-remitting multiple sclerosis: a randomised, placebo-controlled, phase 2 trial","volume":"15","author":"Voskuhl","year":"2016","journal-title":"Lancet Neurol."},{"issue":"297","key":"10.1016\/j.jsbmb.2016.01.006_bib0475","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aab1290","article-title":"The prodrug DHED selectively delivers 17beta-estradiol to the brain for treating estrogen-responsive disorders","volume":"7","author":"Prokai","year":"2015","journal-title":"Sci. Transl. Med."},{"issue":"10","key":"10.1016\/j.jsbmb.2016.01.006_bib0480","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1007\/s00204-012-0868-5","article-title":"Estrogen receptors and human disease: an update","volume":"86","author":"Burns","year":"2012","journal-title":"Arch. Toxicol."},{"issue":"3","key":"10.1016\/j.jsbmb.2016.01.006_bib0485","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1111\/j.1471-4159.2004.02388.x","article-title":"Comparison of in vivo and in vitro subcellular localization of estrogen receptors alpha and beta in oligodendrocytes","volume":"89","author":"Zhang","year":"2004","journal-title":"J. Neurochem."},{"issue":"3","key":"10.1016\/j.jsbmb.2016.01.006_bib0490","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1111\/j.1471-4159.2004.02370.x","article-title":"17beta-estradiol protects oligodendrocytes from cytotoxicity induced cell death","volume":"89","author":"Takao","year":"2004","journal-title":"J. Neurochem."},{"issue":"47","key":"10.1016\/j.jsbmb.2016.01.006_bib0495","doi-asserted-by":"crossref","first-page":"19125","DOI":"10.1073\/pnas.1311763110","article-title":"Estrogen receptor (ER) beta expression in oligodendrocytes is required for attenuation of clinical disease by an ERbeta ligand","volume":"110","author":"Khalaj","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jsbmb.2016.01.006_bib0500","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.nbd.2013.04.005","article-title":"Estrogen receptor beta ligand therapy activates PI3K\/Akt\/mTOR signaling in oligodendrocytes and promotes remyelination in a mouse model of multiple sclerosis","volume":"56","author":"Kumar","year":"2013","journal-title":"Neurobiol. Dis."},{"issue":"2","key":"10.1016\/j.jsbmb.2016.01.006_bib0505","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1002\/glia.20742","article-title":"The localization and non-genomic function of the membrane-associated estrogen receptor in oligodendrocytes","volume":"57","author":"Hirahara","year":"2009","journal-title":"Glia"},{"issue":"4","key":"10.1016\/j.jsbmb.2016.01.006_bib0510","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1172\/JCI32796","article-title":"Estrogen receptor beta protects against acoustic trauma in mice","volume":"118","author":"Meltser","year":"2008","journal-title":"J. Clin. Invest."},{"issue":"1","key":"10.1016\/j.jsbmb.2016.01.006_bib0515","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1002\/jnr.21841","article-title":"Brain-derived neurotrophic factor effects on oligodendrocyte progenitors of the basal forebrain are mediated through trkB and the MAP kinase pathway","volume":"87","author":"Van't Veer","year":"2009","journal-title":"J. Neurosci. Res."},{"issue":"7","key":"10.1016\/j.jsbmb.2016.01.006_bib0520","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1002\/glia.20969","article-title":"BDNF+\/\u2212 mice exhibit deficits in oligodendrocyte lineage cells of the basal forebrain","volume":"58","author":"Vondran","year":"2010","journal-title":"Glia"},{"issue":"1","key":"10.1016\/j.jsbmb.2016.01.006_bib0525","doi-asserted-by":"crossref","first-page":"e00108","DOI":"10.1042\/AN20120092","article-title":"mTOR: a link from the extracellular milieu to transcriptional regulation of oligodendrocyte development","volume":"5","author":"Wood","year":"2013","journal-title":"ASN Neuro"},{"issue":"1\u20132","key":"10.1016\/j.jsbmb.2016.01.006_bib0530","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.jns.2009.04.023","article-title":"Neuroprotective and anti-inflammatory effects of estrogen receptor ligand treatment in mice","volume":"286","author":"Tiwari-Woodruff","year":"2009","journal-title":"J. Neurol. Sci."},{"issue":"25","key":"10.1016\/j.jsbmb.2016.01.006_bib0535","doi-asserted-by":"crossref","first-page":"6823","DOI":"10.1523\/JNEUROSCI.0453-06.2006","article-title":"Treatment with an estrogen receptor alpha ligand is neuroprotective in experimental autoimmune encephalomyelitis","volume":"26","author":"Morales","year":"2006","journal-title":"J. Neurosci."},{"issue":"37","key":"10.1016\/j.jsbmb.2016.01.006_bib0540","doi-asserted-by":"crossref","first-page":"14813","DOI":"10.1073\/pnas.0703783104","article-title":"Differential neuroprotective and antiinflammatory effects of estrogen receptor (ER) alpha and ERbeta ligand treatment","volume":"104","author":"Tiwari-Woodruff","year":"2007","journal-title":"Proc. Nal. Acad. Sci. U. S. A."},{"issue":"50","key":"10.1016\/j.jsbmb.2016.01.006_bib0545","doi-asserted-by":"crossref","first-page":"18061","DOI":"10.1073\/pnas.1411294111","article-title":"Multiple functional therapeutic effects of the estrogen receptor \u03b2 agonist indazole-Cl in a mouse model of multiple sclerosis","volume":"111","author":"Moore","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"4","key":"10.1016\/j.jsbmb.2016.01.006_bib0550","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1517\/13543771003657164","article-title":"Estrogen receptor beta selective nonsteroidal estrogens: seeking clinical indications","volume":"20","author":"Mohler","year":"2010","journal-title":"Expert Opin. Ther. Pat."},{"issue":"4","key":"10.1016\/j.jsbmb.2016.01.006_bib0555","first-page":"365","article-title":"MF-101, an estrogen receptor beta agonist for the treatment of vasomotor symptoms in peri- and postmenopausal women","volume":"10","author":"Stovall","year":"2009","journal-title":"Curr. Opin. Invest. Drugs"},{"issue":"7","key":"10.1016\/j.jsbmb.2016.01.006_bib0560","doi-asserted-by":"crossref","first-page":"e6271","DOI":"10.1371\/journal.pone.0006271","article-title":"Drug and cell type-specific regulation of genes with different classes of estrogen receptor beta-selective agonists","volume":"4","author":"Paruthiyil","year":"2009","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.jsbmb.2016.01.006_bib0565","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1002\/med.20186","article-title":"Estrogen receptor beta ligands: recent advances and biomedical applications","volume":"31","author":"Minutolo","year":"2011","journal-title":"Med. Res. Rev."},{"issue":"1","key":"10.1016\/j.jsbmb.2016.01.006_bib0570","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1021\/jm201436k","article-title":"Diarylpropionitrile (DPN) enantiomers: synthesis and evaluation of estrogen receptor beta-selective ligands","volume":"55","author":"Carroll","year":"2011","journal-title":"J. Med. Chem."},{"issue":"10","key":"10.1016\/j.jsbmb.2016.01.006_bib0575","doi-asserted-by":"crossref","first-page":"4241","DOI":"10.1210\/en.2003-0550","article-title":"Evaluation of an estrogen receptor-beta agonist in animal models of human disease","volume":"144","author":"Harris","year":"2003","journal-title":"Endocrinology"},{"issue":"3","key":"10.1016\/j.jsbmb.2016.01.006_bib0580","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1038\/nn2057","article-title":"Activation of estrogen receptor-beta regulates hippocampal synaptic plasticity and improves memory","volume":"11","author":"Liu","year":"2008","journal-title":"Nat. Neurosci."},{"issue":"1","key":"10.1016\/j.jsbmb.2016.01.006_bib0585","doi-asserted-by":"crossref","first-page":"630","DOI":"10.4049\/jimmunol.180.1.630","article-title":"Selective estrogen receptor-beta agonists repress transcription of proinflammatory genes","volume":"180","author":"Cvoro","year":"2008","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.jsbmb.2016.01.006_bib0590","first-page":"149","article-title":"Preclinical characterization of selective estrogen receptor beta agonists: new insights into their therapeutic potential","volume":"2006","author":"Harris","year":"2016","journal-title":"Ernst Schering Found Symp. Proc."},{"issue":"2","key":"10.1016\/j.jsbmb.2016.01.006_bib0595","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1677\/joe.1.06063","article-title":"Suppression of experimental autoimmune encephalomyelitis using estrogen receptor-selective ligands","volume":"185","author":"Elloso","year":"2005","journal-title":"J. Endocrinol."},{"issue":"11","key":"10.1016\/j.jsbmb.2016.01.006_bib0600","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1002\/acr.20275","article-title":"Efficacy and safety of a selective estrogen receptor-beta agonist, ERB-041, in patients with rheumatoid arthritis","volume":"62","author":"Roman-Blas","year":"2010","journal-title":"Arthritis Care Res. (Hoboken)"},{"issue":"40","key":"10.1016\/j.jsbmb.2016.01.006_bib0605","doi-asserted-by":"crossref","first-page":"13454","DOI":"10.1523\/JNEUROSCI.3264-10.2010","article-title":"Estrogen receptor \u03b2 activity modulates synaptic signaling and structure","volume":"30","author":"Srivastava","year":"2010","journal-title":"J. Neurosci."},{"issue":"4","key":"10.1016\/j.jsbmb.2016.01.006_bib0610","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.cell.2011.03.050","article-title":"An ADIOL-ERbeta-CtBP transrepression pathway negatively regulates microglia-mediated inflammation","volume":"145","author":"Saijo","year":"2011","journal-title":"Cell"},{"issue":"24","key":"10.1016\/j.jsbmb.2016.01.006_bib0615","doi-asserted-by":"crossref","first-page":"4230","DOI":"10.1021\/jm010254a","article-title":"Estrogen receptor-beta potency-selective ligands: structure-activity relationship studies of diarylpropionitriles and their acetylene and polar analogues","volume":"44","author":"Meyers","year":"2001","journal-title":"J. Med. Chem."},{"issue":"4","key":"10.1016\/j.jsbmb.2016.01.006_bib0620","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1210\/en.2008-1355","article-title":"Estrogen receptor-beta agonist diarylpropionitrile: biological activities of R- and S-enantiomers on behavior and hormonal response to stress","volume":"150","author":"Weiser","year":"2009","journal-title":"Endocrinology"},{"issue":"10","key":"10.1016\/j.jsbmb.2016.01.006_bib0625","doi-asserted-by":"crossref","first-page":"2999","DOI":"10.1093\/brain\/awq237","article-title":"Oestrogen receptor beta ligand: a novel treatment to enhance endogenous functional remyelination","volume":"133","author":"Crawford","year":"2010","journal-title":"Brain: J. Neurol."},{"issue":"26","key":"10.1016\/j.jsbmb.2016.01.006_bib0630","doi-asserted-by":"crossref","first-page":"10924","DOI":"10.1523\/JNEUROSCI.0886-13.2013","article-title":"Estrogen mediates neuroprotection and anti-inflammatory effects during EAE through ERalpha signaling on astrocytes but not through ERbeta signaling on astrocytes or neurons","volume":"33","author":"Spence","year":"2013","journal-title":"J. Neurosci."},{"issue":"4","key":"10.1016\/j.jsbmb.2016.01.006_bib0635","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1021\/jm049223g","article-title":"Indazole estrogens: highly selective ligands for the estrogen receptor beta","volume":"48","author":"De Angelis","year":"2005","journal-title":"J. Med. Chem."},{"issue":"Pt. B","key":"10.1016\/j.jsbmb.2016.01.006_bib0640","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.arr.2015.08.001","article-title":"Estrogen receptor \u03b2 in Alzheimer\u2019s disease: from mechanisms to therapeutics","volume":"24","author":"Zhao","year":"2015","journal-title":"Ageing Res. Rev."},{"issue":"1\u20132","key":"10.1016\/j.jsbmb.2016.01.006_bib0645","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.jneuroim.2009.01.003","article-title":"A follow-up study of chromosome 19q13 in multiple sclerosis susceptibility","volume":"208","author":"Bonetti","year":"2009","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jsbmb.2016.01.006_bib0650","first-page":"757432","article-title":"5-Androstenediol ameliorates pleurisy, septic shock, and experimental autoimmune encephalomyelitis in mice","volume":"2010","author":"Nicoletti","year":"2010","journal-title":"Autoimmune Dis."},{"issue":"9","key":"10.1016\/j.jsbmb.2016.01.006_bib0655","doi-asserted-by":"crossref","first-page":"3543","DOI":"10.1073\/pnas.1300313110","article-title":"Targeting estrogen receptor beta in microglia and T cells to treat experimental autoimmune encephalomyelitis","volume":"110","author":"Wu","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"4","key":"10.1016\/j.jsbmb.2016.01.006_bib0660","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1093\/humrep\/deh711","article-title":"A selective estrogen receptor-beta agonist causes lesion regression in an experimentally induced model of endometriosis","volume":"20","author":"Harris","year":"2005","journal-title":"Hum. Reprod."},{"issue":"8","key":"10.1016\/j.jsbmb.2016.01.006_bib0665","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1086\/651276","article-title":"Estrogen receptor beta agonism increases survival in experimentally induced sepsis and ameliorates the genomic sepsis signature: a pharmacogenomic study","volume":"201","author":"Christaki","year":"2010","journal-title":"J. Infect. Dis."}],"container-title":["The Journal of Steroid Biochemistry and Molecular Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960076016300061?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960076016300061?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T23:54:03Z","timestamp":1760745243000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960076016300061"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6]]},"references-count":133,"alternative-id":["S0960076016300061"],"URL":"https:\/\/doi.org\/10.1016\/j.jsbmb.2016.01.006","relation":{},"ISSN":["0960-0760"],"issn-type":[{"value":"0960-0760","type":"print"}],"subject":[],"published":{"date-parts":[[2016,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nudging oligodendrocyte intrinsic signaling to remyelinate and repair: Estrogen receptor ligand effects","name":"articletitle","label":"Article Title"},{"value":"The Journal of Steroid Biochemistry and Molecular Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsbmb.2016.01.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}